Kite Pharma Files For IPO

Santa Monica-based Kite Pharma, a biopharmaceuticals firm focused on treating cancer, has filed for an IPO, saying in a filing Monday evening that it is looking to raised $115M in its offering. The company has applied to list on the NASDAQ Global Market under the symbol KITE. The IPO is being underwritten by Jefferies, Credit Suisse, Cowen and Company, and Stifel. Kite Pharma's indistutional backers include Pontifax, Alta Partners, and Commercial Street Capital.